Tumor-Associated Macrophages in Glioma: Friend or Foe?

Figure 4

Frequency and functional changes in tumor-associated macrophages and microglia (TAMs) in ex vivo tumor specimens over the course of tumor development. While the percentage of TAMs (CD11b⁺CD45⁺ cells) was increased by the final time point (1.1% versus 5.6%, 𝑃=0.017), their functional capacity was impaired as measured by TNF-α expression (25.2% versus 10.9%, 𝑃=0.007). Thirteen mice were analyzed at 13 dpi (𝑛=4), 26 dpi (𝑛=4), and at 29 dpi upon exhibiting clinical tumor morbidity (𝑛=1) or at 40 dpi (𝑛=4). Differences between the means at each time point were tested using two-sided t-tests with unequal variances. ^∗𝑃<0.05, ^∗∗𝑃<0.01, ^∗∗∗𝑃<0.001. Published with permission from Kennedy et al. [21].